• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缩乳术中非增生性和癌前病变的发生率:273 例评估。

The incidence of non-proliferative and precancerous lesions of reduction mammoplasty: evaluation of 273 cases.

机构信息

Plastic and Reconstructive Surgery Department, Inonu University School of Medicine, Malatya Turkey.

出版信息

Eur Rev Med Pharmacol Sci. 2011 Oct;15(10):1207-11.

PMID:22165684
Abstract

BACKGROUND

Reduction mammoplasty (RM) is one of the most commonly performed plastic surgery procedures to treat symptomatic macromasty or to correct asymmetry. Occult breast carcinomas were rarely defined in RM specimens. There are few studies aiming to define the incidence of non-proliferative and precancerous lesions.

MATERIAL AND METHODS

We evaluated the pathological findings of the RM specimens that have been submitted to our Center for the last 6 years (2005-2011).

RESULTS

A total of 273 cases with bilateral RM were enrolled to the study. Of them, 229 cases had pathological changes. Eight cases (2.9%) had atypical ductal/lobular hyperplasia. One case (0.3%) had lobular carcinoma in situ; however, no invasive breast carcinoma was detected. Other pathological findings included fibrocystic changes, fibrosis, adenosis, fibroadenoma (without complex features), mastitis and duct ectasia.

CONCLUSIONS

Pathological examination of the RM specimens is quite important to define the lesions precancerous of breast carcinoma. Unknown occult breast lesions could be identified and early interventions may be taken into account.

摘要

背景

缩乳术(RM)是治疗有症状的巨乳症或矫正乳房不对称的最常见的整形手术之一。隐匿性乳腺癌在 RM 标本中很少被定义。很少有研究旨在定义非增生性和癌前病变的发病率。

材料和方法

我们评估了过去 6 年来(2005-2011 年)提交给我们中心的 RM 标本的病理发现。

结果

共有 273 例双侧 RM 病例纳入研究。其中,229 例有病理改变。8 例(2.9%)有非典型导管/小叶增生。1 例(0.3%)有小叶原位癌;然而,没有检测到浸润性乳腺癌。其他病理发现包括纤维囊性改变、纤维化、腺病、纤维腺瘤(无复杂特征)、乳腺炎和导管扩张。

结论

RM 标本的病理检查对于定义乳腺癌前病变非常重要。可以识别未知的隐匿性乳腺病变,并考虑早期干预。

相似文献

1
The incidence of non-proliferative and precancerous lesions of reduction mammoplasty: evaluation of 273 cases.缩乳术中非增生性和癌前病变的发生率:273 例评估。
Eur Rev Med Pharmacol Sci. 2011 Oct;15(10):1207-11.
2
Incidental atypical proliferative lesions in reduction mammoplasty specimens in patients with a history of breast cancer.乳腺癌病史患者乳房缩小成形术标本中偶然出现的非典型增生性病变。
Hum Pathol. 2014 Jan;45(1):104-9. doi: 10.1016/j.humpath.2013.08.010. Epub 2013 Oct 31.
3
Incidental atypical proliferative lesions in reduction mammoplasty specimens: analysis of 2498 cases from 2 tertiary women's health centers.在缩胸术标本中偶然发现的非典型增生性病变:来自 2 个三级妇女保健中心的 2498 例分析。
Hum Pathol. 2013 Sep;44(9):1877-81. doi: 10.1016/j.humpath.2013.02.015. Epub 2013 May 6.
4
Reduction mammaplasty specimens and occult breast carcinomas.缩乳术标本与隐匿性乳腺癌
Eur J Surg Oncol. 2005 Feb;31(1):19-21. doi: 10.1016/j.ejso.2004.07.026.
5
Pathologic findings in breast reduction specimens: detection of occult premalignant and cancerous lesions.缩乳标本的病理检查结果:隐匿性癌前病变和癌性病变的检测
Onkologie. 2012;35(10):583-6. doi: 10.1159/000342701. Epub 2012 Sep 18.
6
Stereotaxic fine needle aspiration cytology of clinically occult malignant and premalignant breast lesions.临床隐匿性乳腺恶性和癌前病变的立体定向细针穿刺细胞学检查
Acta Cytol. 1988 Mar-Apr;32(2):193-201.
7
Pathologic findings in reduction mammaplasty specimens.缩乳术标本的病理检查结果。
Am J Clin Pathol. 2003 Sep;120(3):377-80. doi: 10.1309/4kd652hn739xtlm3.
8
Histological findings in breast tissue specimens from reduction mammoplasties.缩乳术乳腺组织标本的组织学发现。
Pathol Res Pract. 1994 Sep;190(8):792-8. doi: 10.1016/S0344-0338(11)80427-9.
9
Lobular carcinoma in situ diagnosed by core needle biopsy: when should it be excised?经粗针活检诊断的小叶原位癌:何时应进行切除?
Mod Pathol. 2003 Feb;16(2):120-9. doi: 10.1097/01.MP.0000051930.68104.92.
10
Frequency of clinically occult intraepithelial and invasive neoplasia in reduction mammoplasty specimens: a study of 516 cases.缩乳术标本中临床隐匿性上皮内瘤变和浸润性肿瘤的发生率:一项516例病例的研究
Int J Surg Pathol. 2008 Jan;16(1):25-30. doi: 10.1177/1066896907307176.

引用本文的文献

1
Rate of Incidental Pathological Lesions ın Reduction Mammoplasty Specimens and Incidence of Invasive Breast Carcinoma Following Breast Reduction Operation.缩乳术标本中意外病理病变的发生率及缩乳术后浸润性乳腺癌的发病率。
Aesthetic Plast Surg. 2022 Feb;46(1):83-90. doi: 10.1007/s00266-021-02558-z. Epub 2021 Sep 2.
2
Incidental Findings in Reduction Mammoplasty Specimens in Patients with No Prior History of Breast Cancer. An Analysis of 783 Specimens.无乳腺癌病史患者缩乳术标本中的偶然发现。783例标本分析
Pathol Oncol Res. 2018 Jan;24(1):95-99. doi: 10.1007/s12253-017-0230-6. Epub 2017 Apr 8.
3
Radiologically innocuous breast reduction specimens. Should we send them to pathology lab anyway?
放射学检查无异常的缩乳标本。我们是否仍应将其送检病理实验室?
G Chir. 2013 Nov-Dec;34(11-12):302-6.